NASDAQ:TEM

Tempus Ai Stock News

etoro logo Buy TEM
*Your capital is at risk
$50.56
-1.76 (-3.36%)
At Close: Jun 16, 2026
Tempus AI rallies in 2025, but a Hold rank and mixed style scores argue for patience until pricing, FDA, and MRD milestones firm up.
Cathie Wood bought shares of Baidu, WeRide, and Tempus AI on Monday. Baidu has rallied on its rising AI chips business in China, but it's still textbook cheap.
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that ten abstracts have been accepted for presen
Tempus AI's data engine, MRD buildout and ADLT milestones set the stage for faster growth while profitability metrics turn the corner.
Tempus AI's balanced genomics and data engine is scaling fast as profitability metrics improve and 2026 revenue targets approach the billion-plus mark.
TEM expands its clinical AI reach through regulatory wins, a new oncology partnership and a major digital-pathology acquisition.
Tempus AI hopes to leverage artificial intelligence and its massive data set to improve outcomes for patients. It has partnered with nearly all of the top oncology companies.
Tempus (TEM) reported earnings 30 days ago. What's next for the stock?
Tempus AI, Inc. (TEM) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Why Tempus AI Stock Soared This Week

03:18pm, Friday, 28'th Nov 2025
Two Ark Invest ETFs added Tempus AI stock to their holdings last Friday. A BTIG analyst sees significant upside to Tempus AI stock.
TEM's surging Insights revenues, new contracts and expanded AI capabilities highlight its shift toward scalable data-driven growth.
Tempus AI posts its first positive adjusted EBITDA while Butterfly Network pushes revenue gains and efficiency in a rapidly evolving health tech market.
Connor Clark and Lunn Investment Management Ltd. bought a new stake in Tempus AI, Inc. (NASDAQ: TEM) during the second quarter, according to its most recent filing with the Securities and Exchange Com
Tempus AI (NASDAQ: TEM - Get Free Report) and Movano (NASDAQ: MOVE - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Piper Sandler 37th Annual Healthcar
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE